Pink Matcha Slush

Pink Matcha Slush is a 60% indica-dominant hybrid strain renowned for its exceptional potency and captivating aromatic profile. This cultivar delivers a well-rounded experience combining both indica relaxation and sativa stimulation, with THC levels reaching approximately 31%.

The onset is rapid and intense, initiating with a rush of mental clarity and euphoria. Users report heightened sociability, mental sharpness, and an energetic disposition in the initial phase. The high demonstrates remarkable duration, characterized by a consistently uplifting mental state paired with deep physical relaxation. Mental effects progress toward tranquility and contentment while remaining free from anxiety or pessimistic thoughts. A gentle physical sensation of tingling warmth develops, creating a sensation of bodily lightness. The combination progressively deepens into sedation, making this strain best suited for evening use or when rest is the primary objective.

The buds display a dense, substantial structure with coloration ranging from pale green to deep purple hues, generously coated with large resinous trichomes that become increasingly abundant approaching harvest. The flowers emit a powerful sweetness reminiscent of fruit-based beverages. The flavor profile features peach, lemon, tangerine, and mango notes, creating a tropical taste experience comparable to a relaxing seaside atmosphere with cooling, refreshing qualities.

Pink Matcha Slush exhibits vigorous growth once flowering initiates, reaching 100-120cm indoors and up to 2m outdoors. The indica genetics limit excessive vertical stretch while maintaining substantial plant mass. Indoor yields reach 500g/m², while outdoor production ranges from 700-800g per plant in appropriate conditions. The strain thrives outdoors with adequate light exposure and responds well to training techniques including SCROG, SOG, supercropping, and lollipopping.

With stimulating properties and high THC content, this strain addresses chronic stress, emotional instability, depression, persistent exhaustion, and attention-related disorders.